Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-02-02 00:00:00 ET · period of report 2026-02-02 · accession 0001193125-26-033973 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-02-02 | 2026-02-02 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $185.60 | -32.4K | 7,229 | -82% | -$6.02M |
| DT | 2026-02-02 | 2026-02-02 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +32.4K | 39.6K | +448% | +$259.9K |
| DT | 2026-02-02 | 2026-02-02 | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -32.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-02 | S | D | 32,410 | $185.60 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $183.85 and $186.89. |
| 2 | Common | Common Stock | 2026-02-02 | M | A | 32,410 | $8.02 | 39,639 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-02-02 | M | D | 32,410 | $0.00 | 0 | D | $185.60 · 2017-05-27 to 2026-05-27 | 32,410 Common Stock |